Answers are grounded in this paper and cite their sources.
Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening thrombotic microangiopathy characterised by severe thrombocytopenia and microangiopathic haemolytic anaemia (MAHA), often with neurological and renal involvement. Early recognition and timely therapeutic plasma exchange (TPE) are critical to improve survival but can be challenging in the presence of coexisting sepsis and multiorgan dysfunction. We report a 32-year-old previously healthy male who presented with 10 days of systemic symptoms of fever, jaundice and petechial rash, and a generalised tonic-clonic seizure. Examination revealed pallor, icterus, facial puffiness, bilateral pedal oedema and lower-limb petechiae. Laboratory evaluation showed severe anaemia, thrombocytopenia (15 × 10⁹/L), markedly elevated lactate dehydrogenase (LDH), indirect hyperbilirubinaemia, low haptoglobin, low fibrinogen, acute kidney injury (AKI), haematuria and proteinuria. Peripheral smear demonstrated schistocytes and microspherocytes, consistent with MAHA. Infectious workup was initially negative, but serial blood cultures later grew Escherichia coli, Enterococcus faecium and Stenotrophomonas maltophilia, confirming sepsis. Bone marrow examination showed erythroid hyperplasia with megakaryocytic thrombocytopenia, and ADAMTS13 activity was reduced to 22.5% without pathogenic variants on gene analysis, supporting immune-mediated TTP. The patient was managed with early TPE (six sessions), high-dose corticosteroids, renal replacement therapy for oliguric AKI and culture-directed antibiotics. His course was complicated by Fournier's gangrene requiring surgical debridement and secondary closure, and by pressure sores, but he ultimately achieved haematological remission and recovery of organ function. This case underscores the importance of a high index of suspicion for TTP in patients with fever, thrombocytopenia and haemolytic anaemia, the pivotal role of peripheral smear examination in emergency settings and the need to initiate empirical TPE and immunosuppression without waiting for ADAMTS13 results, even in the presence of confounding sepsis.
No takes yet. Share an insight, caveat, or question.
Shubham Tikkiwal (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: